BioConvergence pour la
Santé
Domaine d’Intérêt Majeur (DIM) de la Région Île-de-France
What is Bioconvergence?
Bioconvergence is the integration of biology with other fields like engineering, physics, and data science to create innovative solutions in healthcare, biotechnology, and beyond. It involves combining the principles and tools of these disciplines to address complex biological challenges more effectively. By merging biological systems with technological advancements, bioconvergence enables breakthroughs in areas such as precision medicine, advanced therapeutics, and biofabrication. This interdisciplinary approach accelerates the development of novel diagnostics, treatments, and sustainable biomanufacturing processes, fostering a new era of innovation that leverages the strengths of diverse scientific domains.
Our 2024 postdoc call is open
Our 2024 postdoc call, which will fund 2 postdoctoral 2-year fellowships in the field of synthetic biology for health, is open until January 30th, 2025. This call will fund fellowships for a project in collaboration between two academic research laboratories; an...
BioConvS at Medicen Day 2024
BioConvS will be present at Medicen Day on October 1st! Medicen Day 2024, une journée pour fédérer l’excellence scientifique et industrielle francilienne Le pôle de compétitivité Medicen Paris Region organise une nouvelle édition de son évènement éponyme, le...
SynBioTherapy
Join us to discuss the synergies between synthetic biology and biotherapies to shape the healthcare of the future!When: November 27th, 2024 Where: Auditorium of the Learning Planet Institute, 8bis rue Charles V 75004 ParisThis conference, co-organized by DIM BioConvS,...
Innovation Day 2024
More than 30 posters were selected for the poster presentation. Browse the abstract in advance so that you can make the best of the poster session!Discover keynotes, short talks and much moreTechnological platforms, funding agencies, innovation experts and more....
iGEM projects 2024
For the 2024 iGEM edition, 3 iGEM teams were created in Ile-de-France. Each of them received an equal financial support from the DIM BioConvS for their project.PANCE-EVO.T7 iGEM Evry Paris-Saclay The aim of our project is to develop a powerful directed evolution tool...
iGEM projects 2023
For 2023, 4 iGEM teams were created in Ile-de-France. Each of them received an equal financial support from the DIM BioConvS for their project.OptoGen EYEsis: evolution of microbial opsins for Retinal Therapy iGEM Evry Paris-Saclay Opsins are light sensitive proteins...
Biofoundries: a revolution for research and global economy
In the rapidly evolving field of biotechnology, biofoundries represent a transformative shift in how research and development are conducted. These state-of-the-art facilities combine automation, synthetic biology, and advanced computational tools to accelerate the...
JNBB 2024: visit Genethon, I-Stem and ART-TG
Cécile Martinat (I-Stem), Giuseppe Ronzitti (Genethon), and Anne Galy (ART-TG) invite you to visit their labs! One of the main missions of BioConvS is to catalyze collaborations between its laboratories. In this spirit, we have organized, in collaboration with...
BioConvS at VivaTech 2024
The largest European innovation event dedicated to start-ups and tech took place last week, from May 22 to 25, at Paris Expo, Porte de Versailles. VivaTech aims to be a generalist event, highlighting new technologies in various fields, including health, spread...
What is BioConvS?
BioConvergence for Health (BioConvS) is a Domain of Major Research and Innovation (DIM) funded by the Ile de France region. It aims to structure the communities of synthetic biology, biotherapy and bioproduction to guide the transition from scientific excellence to innovation, and to position Île-de-France region as an international reference in the domain. BioConvS, led by Université Paris Cité in partnership with Sorbonne and Paris-Saclay universities, Curie Institute (PSL), Micalis Institute (INRAe), Evry Genopole cluster, APHP and INSERM groups actors from the public and private sectors and benefits from 12.5M€ support from the Ile de France Region.
Principal axes
BioConvS gathers the Île-de-France scientific community working on the following axes:
- Life sciences engineering and bioproduction
- Development of therapeutics proofs-of-principles
- New, high throughput, standardisable analythic methods
- Digital or AI tools to improve data analysis or modelling in quality control and production methods
- Guarantee an inclusive, ethical, sustainable Bioconvergence
Distributed Biofoundry
BioConvS will support a network of distributed biofounderies (with the participation of Sorbonne University, INRAe, Institut Curie, Genopole and Université Paris Cité) to make technologies for life design and engineering accessible to Île-de-France Region public and private R&D. This will include the acquisition and pooling of high-tech equipment dedicated to the molecular engineering of living systems and bioproduction to create genetic circuits, synthetic cells and bioprocesses on demand.
CollectivE Digital Intelligence Platform (DICE)
BioConvS will develop an AI-supported framework of digital resources to design, document and share BioConvS researchers’ profiles, expertise and projects in a virtual collaborative research space. This platform, open to the general public, will strengthen the capacity for exchange between DIM’s partners and society.
Consult our data protection policy
Address:
DIM BioConvS
Faculté des Sciences - Université Paris Cité
5 rue Thomas Mann 75013 Paris
